The Wall Street Journal Features Modicus Prime

Modicus Prime is highlighted by The Wall Street Journal Venture Capital as a leading provider of computer vision software aimed at automating biologics image analysis. It also announces the company’s recent achievement of securing a $3.5 million investment. Silverton Partners, the leading investor, is prominently featured along with Alumni Ventures, and it is noted that Roger Chen will be joining the company’s board of directors.

Read more about Modicus Prime in the WSJ article.

For those who may not have access, please reach out to info@modicusprime.com directly for more information.

About Modicus Prime

Modicus Prime’s computer vision software automates biologics image analysis and is designed to solve for the cost, legal, and waste liabilities from product quality failures across R&D and manufacturing.  A resident of Johnson & Johnson’s JLABS at the Texas Medical Center, Modicus Prime is venture-backed and has strategic partnerships with organizations including Takeda Pharmaceuticals, Oak Ridge National Laboratory (DOE), Dotmatics, eLabNext (Eppendorf), and PlugandPlay Health. Current implementation areas for the software include biologics, cell and gene therapies (including AAV manufacturing), and vaccines for pharmaceutical manufacturing, CMOs, CDMOs, and CROs.